John McLaughlin is director of research and analytics at ChanceLight Behavioral Health, Therapy and Education, which serves children and young adults with special needs in 27 states.
John McLaughlin
Director of research and analytics
ChanceLight Behavioral Health, Therapy, and Education
From this contributor
Why model autism programs are rare in public schools
The United States is failing most of its half million school-age children with autism by not giving them a good education.
Why model autism programs are rare in public schools
Explore more from The Transmitter
NeuroAI and the hidden complexity of agency
As we attempt to build autonomous artificial-intelligence systems, we're discovering that a capability we take for granted in animals may be much more complex than we imagined.
NeuroAI and the hidden complexity of agency
As we attempt to build autonomous artificial-intelligence systems, we're discovering that a capability we take for granted in animals may be much more complex than we imagined.
Plaque levels differ in popular Alzheimer’s mouse model depending on which parent’s variants are passed down
5XFAD model mice that inherit two disease-related genes from their fathers have double the plaques seen in those with maternal inheritance, a new study shows.
Plaque levels differ in popular Alzheimer’s mouse model depending on which parent’s variants are passed down
5XFAD model mice that inherit two disease-related genes from their fathers have double the plaques seen in those with maternal inheritance, a new study shows.
‘Doctored: Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,’ an excerpt
In his new book, published today, investigative journalist Charles Piller tells the story of the scientific misconduct that shook Alzheimer’s disease research to its core, and the neuroscientist who helped to expose it.
‘Doctored: Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,’ an excerpt
In his new book, published today, investigative journalist Charles Piller tells the story of the scientific misconduct that shook Alzheimer’s disease research to its core, and the neuroscientist who helped to expose it.